STAT+: What to know about Roche’s experimental Alzheimer’s treatment
The next big Alzheimer’s disease study readout is almost here.
Roche is nearing the completion of a pair of clinical trials involving its experimental treatment called gantenerumab. The Swiss pharma giant will announce results from the studies within the next six weeks.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: What to know about Roche’s experimental Alzheimer’s treatment »
